E-ISSN 2149-388X | ISSN 2149-0430
 

Original Research (Original Article) 


The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?

Huseyin Dogu, Abdurrahman Avar Ozdemir.

Abstract
Background: Symptomatic disease requires surgical intervention comprising of posterior fossa decompression with or without an expansile duraplasty. Until date, the optimal surgical treatment for CM-1 has not been delineated. Thus, we evaluated the results to assess the effectiveness of fibrin sealant augmentation in combination with locally harvested autologous pericranium for duraplasty in adult CM-1 decompression.
Materials and Methods: We retrospectively evaluated the cases that were operated due to CM-1. The cases were divided into two groups in which fibrin sealant (FS) was used and not used. There were 15 patients in the first group (FS group) and 16 in the second group (no fibrin sealant (NFS) group). We followed the standardized surgical technique suggested by Stevens and colleagues for CM 1 decompression.
Results: Cerebrospinal fluid (CSF) fistula was not observed in any patient in the FS group. However, in the NFS group, two patients were reported to develop CSF fistula. Although the findings are not statistically significant, these are clinically important.
Conclusion: Use of FS to seal the autologous graft during closure may prevent the occurrence of CSF fistula among patients of CM-1.

Key words: Arnold-Chiari malformation, Type 1, fibrin sealant, autografts, cerebrospinal fluid leakage


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Huseyin Dogu
Articles by Abdurrahman Avar Ozdemir
on Google
on Google Scholar
Article Statistics
 Viewed: 1053
Downloaded: 151
Cited: 0


How to Cite this Article
Pubmed Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J. 2019; 5(1): 65-70. doi:10.5455/umj.20191108075317


Web Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. https://www.ulutasmedicaljournal.com/?mno=16164 [Access: May 23, 2019]. doi:10.5455/umj.20191108075317


AMA (American Medical Association) Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J. 2019; 5(1): 65-70. doi:10.5455/umj.20191108075317



Vancouver/ICMJE Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J. (2019), [cited May 23, 2019]; 5(1): 65-70. doi:10.5455/umj.20191108075317



Harvard Style

Dogu, H. & Ozdemir, . A. A. (2019) The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J, 5 (1), 65-70. doi:10.5455/umj.20191108075317



Turabian Style

Dogu, Huseyin, and Abdurrahman Avar Ozdemir. 2019. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. THE ULUTAS MEDICAL JOURNAL, 5 (1), 65-70. doi:10.5455/umj.20191108075317



Chicago Style

Dogu, Huseyin, and Abdurrahman Avar Ozdemir. "The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?." THE ULUTAS MEDICAL JOURNAL 5 (2019), 65-70. doi:10.5455/umj.20191108075317



MLA (The Modern Language Association) Style

Dogu, Huseyin, and Abdurrahman Avar Ozdemir. "The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?." THE ULUTAS MEDICAL JOURNAL 5.1 (2019), 65-70. Print. doi:10.5455/umj.20191108075317



APA (American Psychological Association) Style

Dogu, H. & Ozdemir, . A. A. (2019) The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. THE ULUTAS MEDICAL JOURNAL, 5 (1), 65-70. doi:10.5455/umj.20191108075317